Inventor
JONES GRAHAM PETER
GB19 patents
⚠️ This page may combine multiple inventors who share the name “JONES GRAHAM PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
15 patentsUS10287258B2May 14, 2019
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB18 citations97
US9522894B2Dec 20, 2016
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB25 citations97
US11773069B2Oct 3, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB6 citations94
US11117874B2Sep 14, 2021
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB15 citations93
US10669245B2Jun 2, 2020
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB16 citations93
US12054465B2Aug 6, 2024
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB3 citations85
US11814359B2Nov 14, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB4 citations85
US11680049B2Jun 20, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673872B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673871B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11667615B2Jun 6, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655223B2May 23, 2023
Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655224B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655221B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655222B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations84
JONES GRAHAM PETER
3 patentsUS8796321B2Aug 5, 2014
Compounds, compositions and methods comprising oxadiazole derivatives
JONES GRAHAM PETER6 citations82
US8236838B2Aug 7, 2012
Compounds, compositions and methods comprising isoxazole derivatives
JONES GRAHAM PETER18 citations82
US8207205B2Jun 26, 2012
Compounds, compositions and methods comprising oxadiazole derivatives
JONES GRAHAM PETER12 citations82